Understand the source comparison
Best Peptides for Sciatica: Research Compound Comparison
BPC-157 Nerve regeneration via VEGFR2 and EGFR upregulation 250–500mcg daily, subcutaneous Multiple animal studies, no human RCTs Strongest evidence for structural nerve repair, zero human safety data for sciatica TB-500 Anti-inflammatory via NF-κB inhibition
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- Nerve regeneration via VEGFR2 and EGFR upregulation
- 250–500mcg daily, subcutaneous
- Multiple animal studies, no human RCTs
- Strongest evidence for structural nerve repair, zero human safety data for sciatica
- TB-500
- Anti-inflammatory via NF-κB inhibition
- 2–5mg twice weekly, subcutaneous or intramuscular
- Pre-clinical only, mechanism well-characterised
- Best option for acute inflammation, limited evidence for chronic cases
- Thymalin
- Systemic immune modulation (Th1/Th2 balance)
- 5–10mg 2–3× weekly, intramuscular
- Russian clinical trials, minimal Western validation
- Plausible for chronic autoimmune-type inflammation, weakest Western research base
- KPV
- Gut-derived anti-inflammatory tripeptide
- 500mcg–1mg daily, subcutaneous
- Emerging research, mostly in vitro
- Theoretical benefit, insufficient data for recommendation